Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life

Current Diabetes Reports

Volumn 13, Issue 2, 2013, Pages 238-244

  Lacroix, Marilyn ^a   Kina, Eralda ^a   Hivert, Marie France ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Early origin; Epigenetics; Fetal determinants; Insulin resistance; Maternal metabolism; Offspring; Pregnancy; Programming

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; INSULIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIRTH WEIGHT; DNA METHYLATION; EPIGENETICS; FEMALE; HUMAN; INSULIN RESISTANCE; MATERNAL OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PLACENTA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROGENY; RISK FACTOR; WEIGHT GAIN;

EID: 84878636185     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0360-x     Document Type: Article

References (64)

1. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RBS, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005;54:3252-7.
2. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006;49:1677-85.
3. Catalano PM. Carbohydrate metabolism and gestational diabetes. Clin Obstet Gynecol. 1994;37:25-38.
4. Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr. 2000;71:1344S-52S.
5. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378:169-81.
6. •• Bouchard L, Hivert MF, Guay SP, St-Pierre J, Perron P, Brisson D. Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration. Diabetes. 2012;61:1272-80. This article demonstrates that maternal glycemia is correlated with DNA methylation levels in the promoter region of ADIPOQ encoding for adiponectin, an adipokine potentially involved in insulin sensitivity pathways.
7. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-23.
8. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-70.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
10. Chen X, Scholl TO. Ethnic differences in C-peptide/insulin/glucose dynamics in young pregnant women. J Clin Endocrinol Metab. 2002;87:4642-6.
11. Retnakaran R, Hanley AJ, Connelly PW, Sermer M, Zinman B. Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: A comparison of Asian, South Asian, and Caucasian women. J Clin Endocrinol Metab. 2006;91:93-7.
12. Gunton JE, Hitchman R, McElduff A. Effects of ethnicity on glucose tolerance, insulin resistance and beta cell function in 223 women with an abnormal glucose challenge test during pregnancy. Aust N Z J Obstet Gynaecol. 2001;41:182-6.
13. Catalano PM, Roman-Drago NM, Amini SB, Sims EA. Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy. Am J Obstet Gynecol. 1998;179:156-65.
14. • McIntyre HD, Chang AM, Callaway LK, Cowley DM, Dyer AR, Radaelli T, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care. 2010;33:356-60. This article reports that leptin, triglycerides, and IGFBP1 levels were associated with insulin resistance measured in a subsample of the women participating to the landmark HAPO study.
15. Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ. Pre-gravid physical activity and reduced risk of glucose intolerance in pregnancy: the role of insulin sensitivity. Clin Endocrinol. 2009;70:615-22.
16. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30 Suppl 2:S112-9.
17. Birnbaum MJ. Turning down insulin signaling. J Clin Invest. 2001;108:655-9.
18. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012;44:659-69.
19. Tok EC, Ertunc D, Bilgin O, Erdal EM, Kaplanoglu M, Dilek S. Association of insulin receptor substrate-1 G972R variant with baseline characteristics of the patients with gestational diabetes mellitus. Am J Obstet Gynecol. 2006;194:868-72.
20. Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes. 1999;48:1807-14.
21. Friedman JE, Kirwan JP, Jing M, Presley L, Catalano PM. Increased skeletal muscle tumor necrosis factor-Alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes. 2008;57:606-13.
22. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RBS, Wilson PW, et al. Associations of adiponectin, resistin, and tumor necrosis factor-Alpha with insulin resistance. J Clin Endocrinol Metab. 2008;93:3165-72.
23. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, et al. TNF-Alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207-13.
24. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.
25. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
26. Hukshorn CJ, Saris WH, Westerterp-Plantenga MS, Farid AR, Smith FJ, Campfield LA. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab. 2000;85:4003-9.
27. Prolo P, Wong ML, Licinio J. Leptin. Int J Biochem Cell Biol. 1998;30:1285-90.
28. Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer JG. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci U S A. 1997;94:11073-8.
29. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3:1029-33.
30. Lappas M, Yee K, Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol. 2005;186:457-65.
31. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes. 2003;52:2951-8.
32. Meller M, Qiu C, Vadachkoria S, Abetew DF, Luthy DA, Williams MA. Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus. Physiol Res. 2006;55:501-12.
33. Enquobahrie DA, Williams MA, Qiu C, Meller M, Sorensen TK. Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol. 2009;200:206.e1-13.
34. McLachlan KA, O'Neal D, Jenkins A, Alford FP. Do adiponectin, TNFalpha, leptin, and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev. 2006;22:131-8.
35. Vahamiko S, Isolauri E, Pesonen U, Koskinen P, Ekblad U, Laitinen K. Dietary sucrose intake is related to serum leptin concentration in overweight pregnant women. Eur J Nutr. 2010;49:83-90.
36. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem. 2003;278:9073-85.
37. Lacroix M, Battista M, Doyon M, Ménard J, Ardilouze JL, Perron P, Hivert M. Lower adiponectin levels at first trimester of pregnancy are associated with increase insulin resistance and higher risk of gestational diabetes mellitus. Diabetes Care. 2013;36:1-7.
38. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia. 2005;48:993-1001.
39. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand. 2004;83:341-7.
40. Mingrone G, Manco M, Mora ME, Guidone C, Iaconelli A, Gniuli D, et al. Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes Care. 2008;31:1872-6.
41. • Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009;32:1076-80. This study presented the impact of maternal obesity (with normal glucose tolerance) on maternal and newborn metabolic profiles: offspring from obese mothers had higher insulin resistance (HOMA-IR) and higher leptin levels measured in cord blood.
42. HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: Associations with maternal body mass index. BJOG. 2010;117:575-84.
43. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes. 1988;37:622-8.
44. •• Krishnaveni GV, Veena SR, Hill JC, Kehoe S, Karat SC, Fall CH. Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children. Diabetes Care. 2010;33:402-4. This article reports the association between GDM exposure and the risk of metabolic abnormality in children; insulin resistance was higher in children exposed to GDM (and the associations were stronger at 9 years of age than at 5 years of age).
45. Boerschmann H, Pfluger M, Henneberger L, Ziegler AG, Hummel S. Prevalence and predictors of overweight and insulin resistance in offspring of mothers with gestational diabetes mellitus. Diabetes Care. 2010;33:1845-9.
46. Egeland GM, Meltzer SJ. Following in mother's footsteps? Mother-daughter risks for insulin resistance and cardiovascular disease 15 years after gestational diabetes. Diabet Med. 2010;27:257-65.
47. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: Association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290-6.
48. Gillman MW, Oakey H, Baghurst PA, Volkmer RE, Robinson JS, Crowther CA. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care. 2010;33:964-8.
49. Bouchard L, Thibault S, Guay SP, Santure M, Monpetit A, St-Pierre J, et al. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care. 2010;33:2436-41.
50. St-Pierre J, Hivert MF, Perron P, Poirier P, Guay SP, Brisson D. IGF2 DNA methylation is a modulator of newborn's fetal growth and development. Epigenetics. 2012;7:1125-32.
51. •• Chiavaroli V, Giannini C, D'Adamo E, de Giorgis T, Chiarelli F, Mohn A. Insulin resistance and oxidative stress in children born small and large for gestational age. Pediatrics. 2009;124:695-702. This article reports the higher insulin resistance observed in children at both ends of the spectrum for birth weight (small and large for gestational age) and the combined deleterious effect of current of excess weight at 6-8 years old.
52. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35:595-601.
53. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia. 1994;37:150-4.
54. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet. 1998;351:173-7.
55. Flanagan DE, Moore VM, Godsland IF, Cockington RA, Robinson JS, Phillips DI. Fetal growth and the physiological control of glucose tolerance in adults: A minimal model analysis. Am J Physiol Endocrinol Metab. 2000;278:E700-6.
56. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab. 2000;85:1401-6.
57. Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V, et al. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes. 1999;48:2422-9.
58. Levy-Marchal C, Jaquet D. Long-term metabolic consequences of being born small for gestational age. Pediatr Diabetes. 2004;5:147-53.
59. Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales CN, et al. ALSPAC study team. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia. 2004;47:1064-70.
60. Veena SR, Krishnaveni GV, Wills AK, Hill JC, Karat SC, Fall CH. Glucose tolerance and insulin resistance in Indian children: relationship to infant feeding pattern. Diabetologia. 2011;54:2533-7.
61. Williams DM, Martin RM, Davey Smith G, Alberti KG, Ben-Shlomo Y, McCarthy A. Associations of infant nutrition with insulin resistance measures in early adulthood: evidence from the Barry-Caerphilly Growth (BCG) study. PLoS One. 2012;7:e34161.
62. Slining MM, Kuzawa CW, Mayer-Davis EJ, Adair LS. Evaluating the indirect effect of infant weight velocity on insulin resistance in young adulthood: A birth cohort study from the Philippines. Am J Epidemiol. 2011;173:640-8.
63. Raghupathy P, Antonisamy B, Geethanjali FS, Saperia J, Leary SD, Priya G, et al. Glucose tolerance, insulin resistance, and insulin secretion in young south Indian adults: relationships to parental size, neonatal size, and childhood body mass index. Diabetes Res Clin Pract. 2010;87:283-92.
64. Pearce MS, Unwin NC, Parker L, Alberti KG. Life course determinants of insulin secretion and sensitivity at age 50 years: the Newcastle thousand families study. Diabetes Metab Res Rev. 2006;22:118-25.